Compile Data Set for Download or QSAR
Report error Found 369 of affinity data for UniProtKB/TrEMBL: P26663
TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241859(US9416154, 1)
Affinity DataEC50:  6.10E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241863(US9416154, 2)
Affinity DataEC50:  3.30E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241860(US9416154, 3)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241864(US9416154, 4)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241861(US9416154, 5)
Affinity DataEC50:  2.30E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241865(US9416154, 6)
Affinity DataEC50:  9.30E+3nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241862(US9416154, 7)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241866(US9416154, 8)
Affinity DataEC50:  1.30E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241900(US9416154, 9)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241867(US9416154, 10)
Affinity DataEC50:  1.50E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241868(US9416154, 11)
Affinity DataEC50:  3.70E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241869(US9416154, 12)
Affinity DataEC50:  3.90E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241870(US9416154, 13)
Affinity DataEC50:  5.80E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241871(US9416154, 14)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241873(US9416154, 16)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241874(US9416154, 17)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241875(US9416154, 18)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241876(US9416154, 19)
Affinity DataEC50: >2.00E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241877(US9416154, 20)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241878(US9416154, 21)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241879(US9416154, 22)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241880(US9416154, 23)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241903(US9416154, 24)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241902(US9416154, 25)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241883(US9416154, 26)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241901(US9416154, 27)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241884(US9416154, 28)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241885(US9416154, 29)
Affinity DataEC50:  4.55E+3nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241896(US9416154, 30)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241897(US9416154, 31)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241881(US9416154, 32)
Affinity DataEC50: >2.00E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241882(US9416154, 33)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241886(US9416154, 34)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241887(US9416154, 35)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241888(US9416154, 38)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241889(US9416154, 39)
Affinity DataEC50: >1.00E+5nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241890(US9416154, 40)
Affinity DataEC50:  2.10E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241891(US9416154, 41)
Affinity DataEC50:  1.80E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241892(US9416154, 42)
Affinity DataEC50:  4.80E+3nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241893(US9416154, 43)
Affinity DataEC50:  1.40E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241894(US9416154, 45 | US9416154, 44)
Affinity DataEC50:  2.00E+3nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM241894(US9416154, 45 | US9416154, 44)
Affinity DataEC50:  2.20E+4nMpH: 7.3 T: 2°CAssay Description:The ability of the nucleoside triphosphate derivatives to inhibit the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase was measured in...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249179(US9457039, 2)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249180(US9457039, 3)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249181(US9457039, 4)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249182(US9457039, 5)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249183(US9457039, 6)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249184(US9457039, 7)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249185(US9457039, 8)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGenome polyprotein [2420-3010](HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM249186(US9457039, 9)
Affinity DataEC50: >1.00E+5nMT: 2°CAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 369 total ) | Next | Last >>
Jump to: